ENvue Medical names Marc Waldman as VP of commercial operations
ENvue Medical Inc. (NASDAQ: FEED) appointed Marc Waldman as Vice President, Commercial, the medical technology company announced. Waldman will lead the company's U.S. commercialization strategy and focus on expanding ENvue's presence beyond its current 38 hospital locations.
Waldman brings over 35 years of medical device industry experience to the Tyler, Texas-based company. He previously served as North America Sales Director for the neonatal enteral feeding portfolio at NeoMed and later Avanos Medical following its acquisition. During his tenure there, he led revenue growth from approximately $39 million to $70 million over three and a half years.
"Marc is a highly accomplished sales leader with extensive GPO and IDN expertise and long-standing relationships throughout U.S. hospitals," said Doron Besser, CEO of ENvue Medical, according to the company's press release.
Before joining ENvue, Waldman served as Principal of West Branch Medical, helping develop the company into a multimillion-dollar maternal-child health distributor. He also held commercial leadership positions at Wren Medical, NOW Medical, Day & Zimmermann, and Vital Signs. Waldman currently serves as Chairperson of GEDSA, the Global Enteral Device Supplier Association.
ENvue Medical specializes in non-invasive solutions for enteral care across clinical and home care settings. The company operates two technology platforms: the ENvue Navigation Platform, an electromagnetic navigation system for feeding tube placement that has FDA 510(k) clearance for adult use, and acoustic-based therapeutic technologies including PainShield and UroShield devices.
You May Also Be Interested In
- Calix names Juergen Lindner as chief marketing officer
- Valion Bio names CFO Lisa Wolf as president and COO after CEO exits
- California Resources completes $63M acquisition of Crimson Midstream
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Definitive Agreement, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share